Medivatus Group ApS: Financial statements 2024
CVR: 40644482
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Medivatus Group ApS (CVR 40644482) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -297,261 compared with DKK -336,195 the year before. Equity in the 2024 report amounted to DKK 573,040. The solvency ratio was 99.3%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -297,261
- Equity
- DKK 573,040
- Total Assets
- DKK 576,928
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 0 | -297 t. | 573 t. | - |
| 2023 | - | 34 t. | -336 t. | 870 t. | - |
| 2022 | - | 958 t. | 2.1 mio. | 1.2 mio. | 1 |
| 2021 | - | 1.8 mio. | -2.2 mio. | -883 t. | 2 |
| 2020 | - | 400 t. | 704 t. | 1.3 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Medivatus Group ApS has published its annual report for 2023. Gross profit came to DKK 33,661, and the net result was DKK -336,195.
About Medivatus Group ApS
Medivatus Group ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helle Katrine Jørgensen and David Gareth Martin. The company is owned by Assegai Holding AS. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -32,614 compared with DKK -297,261 the year before. Equity in the 2025 report amounted to DKK 215,753.